Σύγκριση μεθόδων
Εξετάστε τις επιλεγμένες μεθόδους δίπλα-δίπλα· οι γραμμές που διαφέρουν επισημαίνονται.
| Κλίμακα Μη-Κινητικών Συμπτωμάτων για τη Νόσο Πάρκινσον (NMSS)× | Πολλαπλή Σκλήρυνση Ποιότητα Ζωής-54 (MSQOL-54)× | |
|---|---|---|
| Πεδίο | Νευρολογία | Νευρολογία |
| Οικογένεια | Process / pipeline | Process / pipeline |
| Έτος προέλευσης≠ | 2007 | 1995 |
| Δημιουργός≠ | K. Ray Chaudhuri, National Hospital for Neurology and Neurosurgery, London | Barbara G. Vickrey, UCLA |
| Τύπος≠ | Self-report questionnaire and clinician interview | Self-report questionnaire |
| Θεμελιώδης πηγή≠ | Chaudhuri, K. R., Martinez-Martin, P., Brown, R. G., Sethi, K., Stocchi, F., Odin, P., Ondo, W., Whone, A., Rye, D., Bhattacharya, K., Naidu, Y., Schapira, A. H., Brozova, H., Nutt, J., Macphee, G., Carroll, C., Hilten, J. V., Verschuuren, J., & Bonuccelli, U. (2007). The metric properties of a novel non-motor symptoms scale for Parkinson's disease: Results from an international pilot study. Movement Disorders, 22(13), 1901-1911. DOI ↗ | Vickrey, B. G., Hays, R. D., Genovese, B. J., Myers, L. W., & Ellison, G. W. (1995). Outcomes in Multiple Sclerosis: The Multiple Sclerosis Quality of Life-54 Scale. Health Psychology, 14(1), 34-42. DOI ↗ |
| Εναλλακτικές ονομασίες≠ | Parkinson's Non-Motor Scale, NMSQ, NMS Scale | MS QoL-54 |
| Συναφείς | 4 | 4 |
| Σύνοψη≠ | The NMSS is a comprehensive 30-item scale designed to assess the prevalence and impact of non-motor symptoms (NMS) in Parkinson's disease. Developed by Chaudhuri and colleagues in 2007, it addresses the reality that non-motor features—sleep disorders, mood disturbances, autonomic dysfunction, cognitive impairment, and pain—often cause greater disability and suffering than motor symptoms in many PD patients. The scale is essential for comprehensive PD assessment and is increasingly recognized as a critical outcome measure reflecting true patient burden. | The MSQOL-54 is a disease-specific quality-of-life instrument designed to assess the physical and mental burden of multiple sclerosis on patients' daily functioning and well-being. Developed by Vickrey and colleagues in 1995, it combines the widely-used SF-36 generic health questionnaire with 18 MS-specific items to provide comprehensive measurement of QoL in MS populations. This scale is a cornerstone tool in MS clinical research and patient monitoring. |
| ScholarGateΣύνολο δεδομένων ↗ |
|
|